Singapore markets closed

Amazon.com, Inc. (AMZN.SN)

Santiago - Santiago Delayed Price. Currency in USD
Add to watchlist
180.84+1.34 (+0.75%)
At close: 11:04AM CLST
Full screen
Previous close179.50
Open180.84
Bid161.56 x 0
Ask180.75 x 0
Day's range180.84 - 180.84
52-week range98.27 - 180.84
Volume300
Avg. volume91
Market cap1.882T
Beta (5Y monthly)1.17
PE ratio (TTM)62.14
EPS (TTM)N/A
Earnings dateN/A
Forward dividend & yieldN/A (N/A)
Ex-dividend dateN/A
1y target estN/A
  • Yahoo Finance Video

    Q1 2024 Takeaways: The rise and fall of the Magnificent Seven

    As the first quarter of 2024 draws to a close, Yahoo Finance's Head of News Myles Udland joins Market Domination Overtime to recap the market highlights of the past quarter. The S&P 500 (^GSPC) is closing the quarter at a new record high, marking the best first quarter since 2019. While 2023 saw the Magnificent Seven tech stocks fuel market gains initially, the first quarter of 2024 is ending with only four of those names — Amazon (AMZN), Meta (META), Nvidia (NVDA), and Microsoft (MSFT) — carrying the momentum. Apple (AAPL) continues to struggle, declining for three straight months. As the gains broaden to other sectors of the market, Energy, Materials, Utilities, and Financials all benefited and were the best-performing sectors for the first quarter. For more expert insight and the latest market action, click here to watch this full episode of Market Domination Overtime. Editor's note: This article was written by Angel Smith

  • Fortune

    Why Amazon’s multi-billion dollar AI alliance with Anthropic isn’t the game-changer it needs to remain king of the cloud

    While it's easy to draw comparisons to the Microsoft - OpenAI alliance, Wednesday's move by AWS actually signals just how vulnerable Amazon's cloud empire has become.

  • Benzinga

    Walgreens Is Paying A Hefty Cost For Its Healthcare Transformation But It's Not Giving Up Despite Scary Competition From Amazon

    Like Amazon.com Inc (NASDAQ: AMZN), Walgreens Boots Alliance (NASDAQ: WBA) is going for its piece of the healthcare pie. With its fiscal second quarter report, it topped estimates, but lowered the higher end of its full-year adjusted earnings guidance in response to a challenging macroeconomy. The new CEO, Tim Wentworth, continues to navigate the company out of a rough spot by slashing costs and solidifying the leadership team, but the company's healthcare transformation took its toll on the bot